Resonance Announces Placement and Entitlement Offer to Raise up to $5.1 million
Resonance Health Limited (ASX: RHT) (Resonance or the Company) is pleased to announce its intention to raise up to $5.1 million (before costs) via a placement (Placement) and non-renounceable entitlement offer (Entitlement Offer) (together the Offer).
The issue price for shares offered under both the Placement and Entitlement Offer (New Shares) will be A$0.05 per New Share (Issue Price). This issue price represents a discount of 20% to Resonance’s last closing price of $0.063 on Monday 7 April 2014.
New Shares issued under the Offer will rank pari pasu with existing ordinary shares on issue and an application will be made for their quotation.
The proceeds of the Offer will be used to:
? Further the development of the Company’s MRI based intellectual property including HepaFat-Scan®, a Liver Fibrosis test and other products; and
? General working capital (including costs of the Offer).
placement offer at .05
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.57M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 116743 | 2 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable